The Absolute Authorities
of NAD+.
From a mysterious ferment in a London brewery to six Nobel Prizes, Harvard longevity discoveries, and Dr. Fenton LeBon's patent-pending single-molecule nanotechnology breakthrough.
Why Does NAD+ Restore Human Energy?
You are made of roughly 37 trillion cells. Inside nearly every cell are hundreds of tiny microscopic power plants called mitochondria. Here is how NAD+ keeps the lights on:
1. It Powers Your Cellular Battery
Every calorie you eat must be converted into ATP (the body's pure energy currency). NAD+ is the literal electron shuttle that drives this conversion in your mitochondria. Zero NAD+ equals zero cellular energy.
2. It Activates DNA Repair (Sirtuins)
When you are tired or stressed, your DNA suffers microscopic damage. Sirtuins are the genetic repair crew that fixes DNA, but they cannot work without consuming NAD+ with every single repair.
3. The Delivery Breakthrough
Until Dr. LeBon invented nanoNAD+™, NAD+ was either destroyed by stomach acid or required 8-hour IV needles. Single-molecule 1.92 nm delivery allows intact absorption directly into cells in seconds.
The Doctors, Scientists & Pioneers
Each authority solved a critical scientific piece of the puzzle, leading directly to the modern single-molecule era.
Sir Arthur Harden & William John Young
Biochemists, Lister Institute of Preventive Medicine (London)
“Why does yeast stop fermenting sugar without an unknown heat-stable co-factor?”
Separated boiled yeast juice and discovered a dialyzable, heat-stable molecular factor essential for fermentation. They named it 'coferment' (later called cozymase).
Proved for the very first time in scientific history that cellular life cannot burn sugar into energy without a vital coenzyme.
Hans von Euler-Chelpin
Professor of Chemistry, Stockholm University
“What is cozymase actually made of at the chemical bond level?”
Purified cozymase into crystals and identified its twin building blocks: a nicotinamide (Vitamin B3) group bonded to an adenine nucleotide. Coined the name Nicotinamide Adenine Dinucleotide (NAD+).
Gave humanity the molecular blueprint of NAD+, proving that our body's core energy molecule is built from Vitamin B3.
Otto Warburg
Director, Kaiser Wilhelm Institute for Cell Physiology (Berlin)
“How do living cells transfer energy from food into cellular breathing?”
Discovered that NAD+ is the universal hydrogen and electron carrier in cellular respiration. He showed that NAD+ accepts electrons from food to become NADH, then delivers them to oxygen to generate cellular power.
Established that NAD+ functions as the re-chargeable battery shuttle powering 90% of the energy produced in human cells.
Conrad Elvehjem
Biochemist, University of Wisconsin–Madison
“What dietary nutrient prevents the deadly epidemic of pellagra?”
Isolated nicotinic acid (Niacin) from liver extracts and proved it instantly cured black tongue in canines and pellagra in humans by replenishing internal NAD+ stores.
Directly connected daily nutrition to cellular energy reserves, eradicating pellagra and proving NAD+ is essential for human survival.
Arthur Kornberg
Biochemist, Washington University / Stanford University
“How do human cells synthesize their own NAD+ internally?”
Discovered the enzyme NAD+ synthetase and mapped the step-by-step biochemical reactions cells use to construct NAD+ from nicotinamide mononucleotide (NMN) and ATP.
Unlocked the enzymatic assembly line of human energy, laying the foundation for modern precursor therapies (NMN and NR).
Leonard Guarente, PhD & David Sinclair, PhD
Molecular Biologists & Geneticists, MIT & Harvard Medical School
“Is NAD+ just for burning food, or does it control the speed of human aging?”
Discovered that Sirtuins (SIRT1–SIRT7)—the master longevity and DNA-repair enzymes—are strictly NAD+-dependent. When NAD+ levels fall as humans age, Sirtuins turn off, accelerating cellular aging.
Proved that restoring NAD+ is not just about daily stamina, but about cellular rejuvenation, DNA repair, and extending human healthspan.
Charles Brenner, PhD & Shin-ichiro Imai, MD, PhD
Metabolic Biochemists, Dartmouth / City of Hope / Washington University
“How does the body absorb oral precursors (NR & NMN), and why do levels drop 50% by age 50?”
Dr. Brenner identified the Nicotinamide Riboside (NR) salvage pathway (NRK enzymes). Dr. Imai mapped the Slc12a8 NMN transporter and documented the steep systemic decline of NAD+ across human tissues.
Quantified the 46-Year Precipice: humans lose up to 50% of their NAD+ by mid-life, creating the global clinical demand for effective replenishment.
Dr. Richard Mestayer, MD
Psychiatrist & Addiction Medicine Pioneer, Founder of Springfield Wellness Center (2001)
“Can high-dose intact NAD+ reverse acute neuro-exhaustion, addiction, and brain trauma?”
Pioneered therapeutic intravenous NAD+ protocols in North America. Over two decades and more than 20,000 clinical infusions, proved intact NAD+ rapidly restores neurotransmitters, halts severe cravings, and clears cognitive trauma.
Established the clinical gold standard for medical NAD+ therapy, while revealing the need for a non-invasive, needle-free delivery method that everyday patients could use at home.
Dr. Fenton G. LeBon, MD, MBA
Physician & Researcher (UF Brain Institute Trained) • Inventor of nanoNAD+™
“How do we overcome the 100-year delivery limitation: standard NAD+ clumps into 50–500nm aggregates too large to enter cells without 8-hour IVs, while oral pills break down in stomach acid?”
Fenton G. LeBon, MD, MBA
Co-Founder & CEO, Molecular World Health
Invented and patented patent-pending single-molecule nanoNAD+™ technology. Using specialized thermodynamic and surfactant isolation, maintains NAD+ at an astonishing ~1.92 nm (confirmed via Dynamic Light Scattering), preventing electrostatic aggregation.
Enables rapid, needle-free transdermal and transmucosal cellular absorption. Delivers 100% intact, un-degraded NAD+ directly into cells and mitochondria in seconds, making true cellular bioenergetics accessible to every human being.
From 1906 to 1.92 Nanometers:
Dr. Fenton LeBon, MD
Trained at the University of Florida Brain Institute and licensed in Florida and Rhode Island, Dr. Fenton LeBon began his quest in 2009 after his father was diagnosed with Parkinson's disease.
Refusing to accept that patients had to sit for 8 hours with needles in their veins to absorb therapeutic NAD+, Dr. LeBon spent years engineering a delivery mechanism that solves the universal clumping problem of the NAD molecule.
Verified via Dynamic Light Scattering (DLS). Small enough to glide directly across stratum corneum and cellular membranes intact.